Glutamate modulation in mood and anxiety disorders: Toward a rational pharmacology?

CNS Spectrums

Volumn 10, Issue 10, 2005, Pages 806-807

  Mathew, Sanjay J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CEFTRIAXONE; CYCLOSERINE; GLUTAMATE RECEPTOR AGONIST; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NEUROTRANSMITTER; PSYCHOTROPIC AGENT;

AMYOTROPHIC LATERAL SCLEROSIS; ANXIETY DISORDER; BEHAVIOR THERAPY; CINGULATE GYRUS; CLINICAL TRIAL; COGNITIVE THERAPY; DRUG EFFICACY; DRUG TARGETING; DRUG TOLERABILITY; EDITORIAL; FEAR; HUMAN; MOOD DISORDER; NEUROIMAGING; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY;

EID: 27444435345     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900010397     Document Type: Editorial

References (4)

1. Moghaddam B, Wolf ME, eds. Glutamate and disorders of cognition and motivation. Ann N Y Acad Sci. 2003;1003:xiv.
2. Peterson BS. Conceptual, methodological, and statistical challenges in brain imaging studies of developmentally based psychopathologies. Dev Psychopathol. 2003;15:811-832.
3. Walker DL, Ressler KJ, Lu KT, Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci. 2002;22:2343-2351.
4. Rothstein JD, Patel S, Regan MR, et al. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature. 2005;433:73-77.